Patents by Inventor Albert E. Heacox

Albert E. Heacox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5257692
    Abstract: A three-envelope package for preserving tissue specimens or other sterile objects. A sterile tissue sample is sealed within an innermost envelope sterile inside and out. The innermost envelope is sealed within the sterile interior of an intermediate envelope equipped with a peel-back seal for subsequent opening. Both the inside and the outside of the intermediate envelope are sterile. The intermediate envelope is sealed within the sterile interior of an outermost envelope, made of foil or another substance impermeable to a storage medium, such as liquid nitrogen. The outermost envelope provides complete impermeability to liquid nitrogen, eliminating the possibility of nitrogen seepage through the peel-back seal of the intermediate envelope. When the envelope package is removed from storage, the intermediate envelope is removed from the outermost envelope and can be opened in an assumed non-sterile environment, without contaminating the innermost envelope or the tissue specimen therein.
    Type: Grant
    Filed: July 15, 1991
    Date of Patent: November 2, 1993
    Assignee: Cryolife, Inc.
    Inventor: Albert E. Heacox
  • Patent number: 5158867
    Abstract: A device for use in cryopreservation of blood vessels comprising a pair of stylets insertable into the ends of a dissected blood vessel segment. The stylets are mountable on a support track whereby the blood vessel can be distended and supported during cryopreservation procedures. Also disclosed is a freezing and thawing profile capable of maximizing endothelial cell survival. The use of chondroitin sulfate or similar compound is discussed as a novel cryoprotectant.
    Type: Grant
    Filed: January 23, 1990
    Date of Patent: October 27, 1992
    Assignees: CryoLife Inc., Medical Univ. of South Carolina
    Inventors: Robert T. McNally, Cameron McCaa, Kelvin G. M. Brockbank, Albert E. Heacox, Harvey L. Bank
  • Patent number: 5149621
    Abstract: A device for use in cryopreservation of blood vessels comprising a pair of stylets insertable into the ends of a dissected blood vessel segment. The stylets are mountable on a support track whereby the blood vessel can be distended and supported during cryopreservation procedures. Also disclosed is a freezing and thawing profile capable of maximizing endothelial cell survival. The use of chondroitin sulfate or similar compound is discussed as a novel cryoprotectant and DMSO is disclosed as a penetrating cyroprotectant.
    Type: Grant
    Filed: January 23, 1990
    Date of Patent: September 22, 1992
    Assignee: CryoLife, Inc. & Medical Univ. of South Carolina
    Inventors: Robert T. McNally, Cameron McCaa, Kelvin G. M. Brockbank, Albert E. Heacox, Harvey L. Bank
  • Patent number: 5145769
    Abstract: A device for use in cryopreservation of blood vessels comprising a pair of styles insertable into the ends of a dissected blood vessel segment. The styles are mountable on a support track whereby the blood vessel can be distended and supported during cryopreservation procedures. Also disclosed is a freezing and thawing profile capable of maximizing endothelial cell survival. The use of chondroitin sulfate or similar compound is discussed as a novel cryoprotectant.
    Type: Grant
    Filed: August 21, 1987
    Date of Patent: September 8, 1992
    Assignees: CryoLife Inc., Medical Univ. of South Carolina
    Inventors: Robert T. McNally, Cameron McCaa, Kelvin G. M. Brockbank, Albert E. Heacox, Harvey L. Bank
  • Patent number: 5122110
    Abstract: A device for use in cryopreservation of blood vessels comprising a pair of stylets insertable into the ends of a dissected blood vessel segment. The stylets are mountable on a support track whereby the blood vessel can be distended and supported during cryopreservation procedures. Also disclosed is a freezing and thawing profile capable of maximizing endothelial cell survival. The use of chondroitin sulfate or similar compound is discussed as a novel cryoprotectant.
    Type: Grant
    Filed: January 23, 1990
    Date of Patent: June 16, 1992
    Assignees: CryoLife, Inc., Medical Univ. of South Carolina
    Inventors: Robert T. McNally, Cameron McCaa, Kelvin G. M. Brockbank, Albert E. Heacox, Harvey L. Bank
  • Patent number: 5031762
    Abstract: A three-envelope package for preserving tissue specimens or other sterile objects. A sterile tissue sample is sealed within an innermost envelope sterile inside and out. The innermost envelope is sealed within the sterile interior of an intermediate envelope equipped with a peel-back seal for subsequent opening. Both the inside and the outside of the intermediate envelope are sterile. The intermediate envelope is sealed within the sterile interior of an outermost envelope, made of foil or another substance impermeable to a storage medium, such as liquid nitrogen. The outermost envelope provides complete impermeability to liquid nitrogen, eliminating the possibility of nitrogen seepage through the peel-back seal of the intermediate envelope. When the envelope package is removed from storage, the intermediate envelope is removed from the outermost envelope and can be opened in an assumed non-sterile environment, without contaminating the innermost envelope or the tissue specimen therein.
    Type: Grant
    Filed: August 17, 1989
    Date of Patent: July 16, 1991
    Inventor: Albert E. Heacox
  • Patent number: RE36071
    Abstract: A three-envelope package for preserving tissue specimens or other sterile objects. A sterile tissue sample is sealed within an innermost envelope sterile inside and out. The innermost envelope is sealed within the sterile interior of an intermediate envelope equipped with a peel-back seal for subsequent opening. Both the inside and the outside of the intermediate envelope are sterile. The intermediate envelope is sealed within the sterile interior of an outermost envelope, made of foil or another substance impermeable to a storage medium, such as liquid nitrogen. The outermost envelope provides complete impermeability to liquid nitrogen, eliminating the possibility of nitrogen seepage through the peel-back seal of the intermediate envelope. When the envelope package is removed from storage, the intermediate envelope is removed from the outermost envelope and can be opened in an assumed non-sterile environment, without contaminating the innermost envelope or the tissue specimen therein.
    Type: Grant
    Filed: April 10, 1996
    Date of Patent: February 2, 1999
    Assignee: CryoLife, Inc.
    Inventor: Albert E. Heacox
  • Patent number: RE36132
    Abstract: A three-envelope package for preserving tissue specimens or other sterile objects. A sterile tissue sample is sealed within an innermost envelope sterile inside and out. The innermost envelope is sealed within the sterile interior of an intermediate envelope equipped with a peel-back seal for subsequent opening. Both the inside and the outside of the intermediate envelope are sterile. The intermediate envelope is sealed within the sterile interior of an outermost envelope, made of foil or another substance impermeable to a storage medium, such as liquid nitrogen. The outermost envelope provides complete impermeability to liquid nitrogen, eliminating the possibility of nitrogen seepage through the peel-back seal of the intermediate envelope. When the envelope package is removed from storage, the intermediate envelope is removed from the outermost envelope and can be opened in an assumed non-sterile environment, without contaminating the innermost envelope or the tissue specimen therein.
    Type: Grant
    Filed: April 10, 1996
    Date of Patent: March 9, 1999
    Assignee: CryoLife, Inc.
    Inventor: Albert E. Heacox